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Abstract
DYT1 early-onset generalized dystonia is a hyperkinetic movement disorder caused by mutations in DYT1 (TOR1A), which
codes for torsinA. Recently, significant progress has been made in studying pathophysiology of DYT1 dystonia using
targeted mouse models. Dyt1 DGAG heterozygous knock-in (KI) and Dyt1 knock-down (KD) mice exhibit motor deficits and
alterations of striatal dopamine metabolisms, while Dyt1 knockout (KO) and Dyt1 DGAG homozygous KI mice show
abnormal nuclear envelopes and neonatal lethality. However, it has not been clear whether motor deficits and striatal
abnormality are caused by Dyt1 mutation in the striatum itself or the end results of abnormal signals from other brain
regions. To identify the brain region that contributes to these phenotypes, we made a striatum-specific Dyt1 conditional
knockout (Dyt1 sKO) mouse. Dyt1 sKO mice exhibited motor deficits and reduced striatal dopamine receptor 2 (D2R) binding
activity, whereas they did not exhibit significant alteration of striatal monoamine contents. Furthermore, we also found
normal nuclear envelope structure in striatal medium spiny neurons (MSNs) of an adult Dyt1 sKO mouse and cerebral
cortical neurons in cerebral cortex-specific Dyt1 conditional knockout (Dyt1 cKO) mice. The results suggest that the loss of
striatal torsinA alone is sufficient to produce motor deficits, and that this effect may be mediated, at least in part, through
changes in D2R function in the basal ganglia circuit.
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Introduction
Dystonia is a movement disorder that is exhibited by
involuntary, repetitive, sustained muscle contractions or abnormal
postures [1]. Dystonia is classified into two groups, primary and
secondary dystonia. Primary dystonia develops spontaneously in
the absence of any apparent cause or associated disease.
Secondary dystonia is caused by other diseases, such as Parkinson’s
or Huntington’s diseases, brain injury, or drug side effects. Genetic
dystonia belongs to the primary dystonia group and is classified
into more than 20 types, although less than half of them have
known gene mutations [2]. DYT1 early-onset generalized torsion
dystonia is an inherited movement disorder and is caused by
mutations in DYT1 (TOR1A) coding for torsinA with about 30%
penetrance [3]. TorsinA is a member of AAA+ family of ATPases
and may work in trafficking of polytopic membrane proteins and
protein processing in the secretory pathway [4,5]. ATPase activity
[6,7] and molecular chaperon activity of torsinA [8] were also
reported in vitro. Nearly all DYT1 dystonia patients have a 3 base-
pairs deletion (DGAG) in DYT1 in one allele, corresponding to a
loss of a glutamic acid residue in the C-terminal region of torsinA
[3], while an 18 bp deletion mutation [9] and an Arg288Gln
missense mutation [10] have been reported. A frame shift
mutation caused by 4 bp-deletion coding for the C-terminal
region of torsinA was also reported in a possible myoclonus-
dystonia patient [11]. Dyt1 DGAG heterozygous KI male mice
exhibit reduction of striatal torsinA and motor deficits [12–14].
Dyt1 KD male mice and Dyt1 cKO mice also exhibit motor
deficits, suggesting loss of torsinA function may contribute to
motor deficits in these Dyt1 mutant mice [15,16]. Ampicillin-
injected Dyt1 DGAG heterozygous KI male mice express normal
level of striatal torsinA and exhibit normal motor performance,
suggesting recovery of torsinA level in the striatum may rescue the
motor deficits in Dyt1 DGAG heterozygous KI male mice [13].
Although DYT1 dystonia patients do not respond to levodopa
treatment in most cases, there are several reports suggesting
functional alterations in the striatal dopaminergic system in DYT1
dystonia. A postmortem dopamine (DA) content analysis in a
DYT1 dystonia patient brain suggested a reduced DA in rostral
portions of the putamen and caudate nucleus [17]. Another
postmortem study reported a reduced dopamine receptor binding
in the striatum and increased striatal 3,4-dihydroxyphenylacetic
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24539acid (DOPAC)/DA ratio in DYT1 dystonia patients [18]. A
positron emission tomography study suggested that striatal D2R
availability is reduced in both manifesting and non-manifesting
DYT1 mutation carriers [19]. Dyt1 DGAG heterozygous KI male
mice exhibit reduced homovanillic acid (HVA) level in the
striatum [12] and Dyt1 KD mice show decreased level of striatal
DOPAC [15]. Moreover a transgenic mouse model overexpress-
ing human mutant torsinA derived by human cytomegalovirus
(CMV) immediate early promoter exhibit a reduction of D2R in
the striatum [20]. These reports suggested that functional
alterations of the striatal dopaminergic system may contribute to
the pathogenesis of DYT1 dystonia, while its precise functional
role has not been well defined. For example, it is not known
whether motor deficits and alterations of the striatal dopaminergic
system are caused by the mutation in the striatum itself or end
results of abnormal signals from other brain regions.
Abnormal nuclear envelopes have been reported in transfected
cells over-expressing the mutant forms of torsinA [21–23], Dyt1
KO mice and Dyt1 DGAG homozygous KI mice exhibiting
neonatal lethality [24]. Both transgenic mice overexpressing
human WT torsinA and mutant torsinA using murine prion
promoter exhibit abnormal nuclear envelopes and abnormal
motor performance [25]. It was suggested that neuron-specific
nuclear envelope abnormality in Dyt1 DGAG homozygous KI
mice is caused by malfunction of torsinA with incomplete
compensation by torsinB which is weakly expressed in neurons
[26]. However, such abnormality has not been found in Dyt1
DGAG heterozygous KI mouse or DYT1 dystonia patient brains,
casting doubts about its role in the pathogenesis of DYT1 dystonia.
In the present study, we hypothesized that a selective loss of
torsinA function in the striatum may affect motor performance in
mice. We used cre-loxP technology [27] applied to mouse gene
recombination [28] to selectively inactivate Dyt1 in the striatum
using a Rgs9-cre line that has restricted recombination in the
striatum [29]. Dyt1 sKO mice were made and their motor
performance, dopaminergic system, and the role of torsinA in
maintaining the nuclear envelope structures were analyzed. Since
abnormal nuclear envelope was reported in cerebral cortical
neurons in Dyt1 KO and Dyt1 DGAG homozygous KI mice, we
further analyzed nuclear envelopes in cerebral cortical neurons of
Dyt1 cKO mice [16].
Results
Making of Dyt1 sKO mice
Rgs9-cre and Dyt1 loxP double heterozygous mice were prepared
by crossing Dyt1 loxP mice [16] and Rgs9-cre mice [29]. Dyt1 sKO
mice were prepared by crossing Rgs9-cre Dyt1 loxP double
heterozygous mice and Dyt1 loxP mice (Fig. 1A). Genotyping was
performed by multiplex PCR with tail DNA (Fig. 1B). Dyt1 sKO
mice were born according to Mendelian ratio and developed to
adult. The striatum-specific deletion of Dyt1 exons 3 and 4 in Dyt1
sKO mice was confirmed by PCR using DNA isolated from each
brain region (Fig. 1C).
No overt abnormal postures and normal locomotion in
Dyt1 sKO mice
When suspended from the tail, both Dyt1 sKO and Control
littermate (CT) mice showed normal splaying of hindpaws and had
no observable hindpaw extension or truncal arching. All mice
exhibited strong righting reflexes when tipped on their side. The
results suggest that Dyt1 sKO mice had no overt abnormal
postures.
Since Dyt1 DGAG heterozygous KI male mice [12] and Dyt1
KD male mice [15] exhibit moderate hyperactivities, and Dyt1
cKO mice exhibit prominent hyperactivities in the open-field test
[16], spontaneous activities in Dyt1 sKO mice were assessed in the
Figure 1. Making of Dyt1 sKO mice. (A) The breeding strategy to
generate Dyt1 sKO mice. Dyt1 loxP mice [16] and Rgs9-cre mice [29]
were prepared as described earlier. Rgs9-cre Dyt1 loxP double
heterozygous mice were prepared by crossing Dyt1 loxP mice and
Rgs9-cre mice. Dyt1 sKO mice were prepared by crossing Rgs9-cre Dyt1
loxP double heterozygous mice and Dyt1 loxP mice. The primer sites to
amplify Dyt1 exons 3 and 4-deleted locus were shown by an arrow pair
under the map. (B) A representative image of the multiplex PCR-based
genotyping. Top bands are PCR products of cre. Middle bands are PCR
products of Dyt1 loxP locus. The bottom bands are PCR products of Dyt1
WT locus. Lanes 1, 3, 5: Dyt1 loxP homozygous mice; Lanes 2, 7: Rgs9-cre
Dyt1 loxP double heterozygous mice; Lanes 4: Dyt1 sKO mouse; Lane 6:
Dyt1 loxP heterozygous mouse. (C) Tissue-specific deletion of Dyt1
exons 3 and 4 in Dyt1sKO mice was confirmed by PCR using DNA
isolated from each brain region. The deletion was detected only in the
striatum of Dyt1sKO mouse as predicted (D). CT: control littermate
mouse.
doi:10.1371/journal.pone.0024539.g001
Striatum-Specific Dyt1 Conditional KO Mice
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sKO mice did not exhibit significant differences in comparison to
CT mice in either horizontal locomotion (Fig. 2A; horizontal
activity, p=0.55; B; total distance, p=0.83; C; movement number,
p=0.54; D; movement time, p=0.91) or vertical locomotion
(Fig. 2E; vertical movement number, p=0.87). There was no
significant difference in stereotypic activity (Fig. 2F; p=0.45),
stereotypic movement time (Fig. 2G; p=0.47), clockwise or anti-
clockwise revolution between Dyt1 sKO mice and CT mice
(Fig. 2H; p=0.90 and p=0.62, respectively). The results suggest
that loss of torsinA in the striatum alone does not affect
spontaneous locomotion.
Significant motor deficits of hindpaws in Dyt1 sKO mice
Motor performance was assessed by the accelerated rotarod and
beam-walking tests. Each mouse was put on the accelerated
rotarod and the latency to fall was measured. Since mice can hold
onto the rotarod with four paws, the latency to fall is an indicator
of total motor performance and shorter latency indicates motor
deficits. Dyt1 sKO mice did not show significant difference in
latency to fall (Fig. 3A; p=0.48), suggesting no motor symptoms in
total motor performance with four paws. We further analyzed the
motor coordination and balance by the beam-walking test. Mice
were trained to transverse a medium square beam for two days.
The trained mice were tested twice on four different beams and
total numbers of hindpaw slips were analyzed. Dyt1 sKO mice
showed 144% more slip numbers in the beam-walking test (Fig. 3B;
p=0.043), suggesting motor deficits in hindpaws.
In the accelerated rotarod test, Dyt1 sKO mice did not exhibit
overt motor deficits with four paws. The result is consistent with
other DYT1 dystonia mouse models. Dyt1 DGAG heterozygous
KI mice [12], Dyt1 KD mice [15] or Dyt1 cKO mice [16] do not
exhibit significant motor deficits either in the accelerated rotarod
tests. On the other hand, Dyt1 sKO mice, Dyt1 cKO mice, Dyt1
DGAG heterozygous KI male mice and Dyt1 KD male mice
Figure 2. Locomotion of Dyt1 sKO mice and CT mice in the open field test. Spontaneous activities in Dyt1 sKO mice were assessed in the
open-field apparatus and compared to those in CT mice. Dyt1 sKO mice did not exhibit significant differences in comparison to CT mice in horizontal
locomotion (A, horizontal activity; B, total distance; C, movement number; D, movement time) or vertical locomotion (E, vertical movement number).
There was no significant difference in stereotypic activity (F), stereotypic movement time (G), clockwise (H, CWREV) or anti-clockwise revolution (H,
ACWREV). Vertical bars represent means 6 standard errors.
doi:10.1371/journal.pone.0024539.g002
Figure 3. Motor performances in Dyt1 sKO mice and CT mice.
(A) Latency to fall in the accelerated rotarod test. Dyt1 sKO mice did not
exhibit significant difference in the latency to fall, suggesting no motor
deficits with four paws. (B) Beam-walking performances in Dyt1 sKO
mice and CT mice. The data in the CT mice were normalized to zero.
Dyt1 sKO mice showed significant increased slips numbers in beam-
walking test, suggesting motor deficits in hindpaws. Vertical bars
represent means 6 standard errors. *p,0.05.
doi:10.1371/journal.pone.0024539.g003
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symptoms commonly start from the legs in DYT1 dystonia
patients, the beam-walking test may be one of the most
appropriate behavior tests to detect the early motor symptoms in
DYT1dystonia mouse models.
Decreased radioligand binding to D2R in the striatal
membrane fractions from Dyt1 sKO mice
We measured radioligand binding activity of [
3H] YM-09151-2
to D2R in the striatal membrane fractions from three Dyt1 sKO
and three CT mice. To see the overall distribution of data,
representative saturation binding curves of [
3H] YM-09151-2
were drawn using the transformed composite data of mean values
obtained for the three Dyt1 sKO (open circles) and three CT (solid
circles) mice (Fig. 4A). The fit lines in the representative Scatchard
plot were also created by least square means from the transformed
composite data of the mean values (Fig. 4B; Dyt1 sKO,
r
2=0.9788; CT, r
2=0.9585) as described [30]. To analyze the
statistical significance of Bmax and Kd, between Dyt1 sKO and CT
mice, Bmax and Kd of each mouse were also individually analyzed in
Scatchard plot and those of each genotype were compared by
Student’s t test as described [31]. The Bmax value for [
3H] YM-
09151-2 binding, reflecting levels of radioligand binding to D2R,
was significantly lower in Dyt1 sKO mice in comparison to CT
mice (means 6 standard errors; Dyt1 sKO, 541628 fmol/mg,
n=3; CT, 793646 fmol/mg, n=3; p=0.009). Receptor affinity
for the ligand as indicated by Kd, however, was unchanged in Dyt1
sKO mice (Dyt1 sKO, 1496 46 pM, n=3; CT, 135612 pM,
n=3;p=0.79).
Normal monoamine contents in the striatum of Dyt1 sKO
mice
To determine whether the motor deficits accompany any
alterations of striatal DA metabolism, we measured concentrations
of DA, DOPAC and HVA in the striatum. Unlike Dyt1 DGAG
heterozygous KI mice or Dyt1 KD mice, the levels of DA, DOPAC
or HVA and the ratios of DOPAC or HVA to DA in the Dyt1
sKO mice were not significantly different from those in CT mice
(Table 1); suggesting loss of torsinA function in the striatum alone
does not affect monoamine contents in the striatum.
Normal nuclear envelopes of neurons in Dyt1 sKO and
Dyt1 cKO mice
To analyze whether loss of torsinA in adult neurons affects
nuclear envelope structures, we examined the nuclear envelope
structures of striatal MSNs in a Dyt1 sKO mouse using a
transmission electron microscopy. We first examined 11 striatal
MSNs in a CT mouse and found no abnormal nuclear envelope as
expected (Fig. 5A, B). Although we examined 29 striatal MSNs of
a Dyt1 sKO mouse, we could not find any blebbing or other
nuclear envelope abnormalities among them (Fig. 5C, D). Since
abnormal nuclear envelope was reported in cerebral cortical
neurons of Dyt1 KO and Dyt1 DGAG homozygous KI mice but
not in their striatal neurons [24], we further analyzed cerebral
cortical neurons in Dyt1 cKO mice to determine whether loss of
torsinA in cerebral cortical neurons contributes to abnormal
envelope in adult mice. Although we examined 50 cerebral
cortical neurons of two CT mice (Fig. 5E, F) and 84 cerebral
cortical neurons of two Dyt1 cKO mice (Fig. 5G, H), we could not
find any blebbing or other nuclear envelope abnormalities among
them, either. Since Dyt1 cKO mice exhibit motor deficits [16],
these results suggest that abnormal nuclear envelope structure is
not a cause of motor impairment in Dyt1 cKO or sKO mice. On
the other hand, we confirmed abnormal nuclear envelopes in the
Figure 4. Radioligand binding activity to D2R in the striatal
membrane fractions. (A) A representative saturation binding curve of
[
3H] YM-09151-2 to the striatal membranes fractions from three Dyt1
sKO (open circles) and three CT (solid circles) mice. The transformed
composite data of mean values obtained for the three mice in each
genotype are plotted. (B) A representative Scatchard transformation of
the data. The fit lines were created by least square means from the
transformed composite data of mean values.
doi:10.1371/journal.pone.0024539.g004
Table 1. DA and its metabolites in the striatum.
Content or ratio CT Dyt1 sKO p
DA 8.6562.36 9.2662.29 0.86
DOPAC 0.8260.12 0.7660.11 0.70
HVA 1.3760.14 1.3660.13 0.98
DOPAC/DA 2.5860.21 2.5160.20 0.82
HVA/DA 3.1960.23 3.1860.22 0.98
The values of neurochemical are shown as mean 6 standard errors (in ng/mg of
wet tissue). The turnovers of metabolites are shown as the ratio of the
neurochemicals after natural log transformation to obtain a normal distribution.
CT: control littermate mice; Dyt1 sKO: striatum-specific Dyt1 conditional
knockout mice.
doi:10.1371/journal.pone.0024539.t001
Striatum-Specific Dyt1 Conditional KO Mice
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gous KI mouse [12] used as a positive control (Fig. 6A–C).
Discussion
Although DYT1 is expressed in multiple brain regions, motor
symptoms are prominent in DYT1 dystonia patients. Reduced
D2R binding activity and alteration of striatal monoamine
metabolism were reported in DYT1 dystonia patients [17–19].
Dyt1 DGAG heterozygous KI male and Dyt1 KD male mice
exhibit motor deficits. Dyt1 DGAG heterozygous KI male mice
exhibit reduced HVA in the striatum [12] and Dyt1 KD mice
exhibit reduced striatal DOPAC [15]. Furthermore, a transgenic
mouse model overexpressing human mutant torsinA derived by
human CMV immediate early promoter show reduction of D2R
in the striatum and impaired LTD which is rescued by
adenosine A2A receptor antagonism [20]. In the same mouse
model, altered responses to D2R activation and N-type calcium
currents in striatal cholinergic interneurons were reported [32].
Moreover anticholinergic drugs are quite effective in clinical
practice [1]. To determine whether the alterations of the
dopaminergic system are cell-autonomous, we made Dyt1 sKO
mice and analyzed their motor performance and dopaminergic
system. Dyt1 sKO mice exhibited motor deficits and reduced
striatal D2R binding activity, whereas they did not exhibit
significant alteration of striatal monoamine contents. MSNs in
the indirect pathway and cholinergic interneurons express D2R
and contribute to synaptic plasticity in the striatum [33,34].
Reduction of D2R may affect signal transduction pathways in
these neurons and affect basal ganglia circuit. Since the loss of
D2R is known to cause motor deficits in mice [31], the present
results suggest that the loss of striatal torsinA affects signal
transduction pathway through D2R in the basal ganglia circuit
and exhibit motor deficits.
Several studies suggest a reduction of striatal D2R binding
activity in DYT1 dystonia patients. A postmortem study reported
a trend of [
3H] YM-09151-2 binding reduction in the striatum
[18]. Another positron emission tomography study also suggested
that the striatal D2R availability was reduced in both manifesting
and non-manifesting DYT1 mutation carriers [19]. However, the
mechanism of the striatal D2R binding activity reduction has not
been known. In the present study, we made Dyt1 sKO mice and
analyzed their D2R binding activity. Bmax value for [
3H] YM-
09151-2 binding activity to D2R was significantly lower in Dyt1
sKO mice in comparison to CT mice, while the receptor affinity to
the ligand as indicated by Kd, was comparable between the
genotypes. The results suggest that the number of functional D2R
may be reduced in the striatal membrane fractions, while the
affinity of the ligand itself is not largely altered. The results also
suggest that reduced striatal D2R binding activity is not an end
result caused by alterations of striatal monoamines, but it is caused
by loss of torsinA function in the striatum itself. It was suggested
that torsinA contributes to protein processing in the secretory
pathway [5]. Over-expression of WT torsinA in vitro also inhibit
trafficking of polytopic membrane proteins [4], suggesting proper
level of torsinA protein is critical for normal protein maturation
and trafficking. Deficient trafficking of D2R caused by loss of
torsinA in the striatum may underlie decreased D2R-binding in
the striatal membrane fractions.
The results suggest that the loss of torsinA function in the
striatum itself contributes to the pathophysiology of DYT1
dystonia. Loss of striatal torsinA may affect signal transduction
pathway through D2R in the basal ganglia circuit and exhibit
motor deficits. This is consistent with the clinical observation that
deep brain stimulation targeting GPi in the basal ganglia circuits is
an effective surgical therapy for DYT1 dystonia [35]. Interestingly,
Dyt1 cKO mice also exhibit similar motor deficits without
alteration of monoamine contents in the striatum [16]. Collec-
tively, our results suggest that loss of torsinA function in the
corticostriatal pathway may affect the basal ganglia circuits and
contribute to motor impairment without alteration of DA
Figure 5. Normal nuclear envelope structure of the striatal
MSNs in Dyt1 sKO and CT mice, and cerebral cortical neurons in
Dyt1 cKO and CT mice. Representative electron microscope images
of the nuclei of the striatal MSNs in CT (A) and Dyt1 sKO mice (C).
Enlarged images of CT (B) and Dyt1 sKO (D) mice clearly show normal
nuclear envelopes in MSNs. Representative electron microscope images
of the nuclei of the cerebral cortical neurons in CT (E) and Dyt1 cKO (G)
mice. Enlarged images of CT (F) and Dyt1 cKO (H) mice also show
normal nuclear envelopes in cerebral cortical neurons. Nucleus (N) and
nuclear envelope (arrow) are shown in each figure. No abnormal
nuclear envelopes of neurons were detected in Dyt1 sKO or Dyt1 cKO
mice as well as CT mice. Magnification in A, C, E, G: 5,0006.
doi:10.1371/journal.pone.0024539.g005
Striatum-Specific Dyt1 Conditional KO Mice
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pathway will elucidate details of the molecular mechanism of this
disease.
A postmortem study reported increased striatal DOPAC/DA
ratio in DYT1 dystonia patients [18]. Dyt1 DGAG heterozygous
KI male mice exhibit decreased HVA [12], while Dyt1 KD mice
exhibited decreased DOPAC [15] in their striata. However, the
mechanism of the striatal monoamine alterations has not been
clear. In the present study, Dyt1 sKO mice did not exhibit
alteration of DA, DOPAC or HVA contents in the striatum,
suggesting that loss of torsinA function in the striatum itself may
not affect monoamine contents in the striatum. The results also
suggest that dopaminergic tone in the striatum may have a
limited role in the pathogenesis of DYT1 dystonia because Dyt1
sKO mice exhibited motor deficit without alteration of striatal
monoamine contents. The results are consistent with the clinical
observation that levodopa is not effective for DYT1 patients. The
significant alterations in the striatal DA metabolites found in Dyt1
DGAG heterozygous KI male mice and Dyt1 KD mice may be
caused by loss of torsinA function in dopaminergic neurons
derived from the substantia nigra. Generating substantia nigra-
specific Dyt1 conditional KO mice in the future may further allow
us to determine the origin of the alterations of DA metabolism
observed in Dyt1 DGAG heterozygous KI male mice and Dyt1
KD mice.
Abnormal nuclear envelopes have been reported in transfected
cells over-expressing the mutant forms of torsinA [21–23].
Abnormal nuclear envelopes were also reported in Dyt1 KO
mice and Dyt1 DGAG homozygous KI mice [24]. However,
abnormal nuclear envelopes were not found in Dyt1 DGAG
heterozygous KI mice which exhibit motor deficits, casting
doubts about its role in the pathogenesis of DYT1 dystonia. To
analyze whether the motor deficits in Dyt1 sKO and cKO mice
are caused by abnormal nuclear envelopes, we examined the
nuclear envelopes of striatal MSNs or cortical neurons. However,
we could not find any blebbing or other nuclear envelope
abnormalities in both Dyt1 sKO and cKO mice, suggesting that
nuclear envelope abnormality may not play any role in motor
impairment seen in these mice. Since abnormal envelopes in vivo
are detected only in neonatal Dyt1 DGAG homozygous KI mice
and Dyt1 KO mice, that exhibit neonatal lethality, the abnormal
nuclear envelope may be an indicator of neuronal cell death in
these dying mice.
Materials and Methods
Making of the striatum-specific Dyt1 conditional
knockout mice
Dyt1 loxP mice [16] and Rgs9-cre mice [29] were prepared as
described earlier. Genotyping for Dyt1 sKO and CT mice was
performed by multiplex PCR using tail DNA with F (59-
ATTCAAAAATGTTGTCATAGCCAGG-39)a n dT( 5 9-CTA-
CAGTGACCTGAATCATGTGGC-39) primer sets for Dyt1 loxP
locus [16], and creA (59-ATCTCCGGTATTGAAACTC-
CAGCGC-39) and cre6 (59-CACTCATGGAAAATAGCGATC-
39) primer sets for cre locus [36]. To confirm the striatum-specific
deletion of Dyt1 exons 3 and 4, the olfactory bulb, striatum,
cerebral cortex, cerebellum, and brainstem were dissected from
Dyt1 loxP and Dyt1 sKO mouse brains. The tissues were digested
with lysis buffer [100 mM TrisNCl (pH 8.5), 5 mM EDTAN2Na,
0.2% SDS, 200 mM NaCl, 1 mM CaCl2, 0.1 mg/ml Proteinase
K (Invitrogen)] at 55uC overnight. Each DNA was isolated by
adding equal volume of isopropanol and then washing with 70%
ethanol. The deletion of exons 3 and 4 was confirmed by PCR
using F and Tcko2 (59-CCATAGCTGGACCTGCAATTAAG-
39) primers as described earlier [16,37]. A group consisted of 11
Dyt1 sKO mice (7 males and 4 females) and 13 CT mice (6 males
and 7 females) was used for the behavior tests. A pair of Dyt1 sKO
and CT mice was used to prepare brain sections for transmission
electron microscopy analysis. Since onset of DYT1 dystonia is
usually childhood or adolescence, we used adult mice in this study.
All experiments were performed by investigators blind to the
genotypes. Mice were housed under a 12 hours-light and
12 hours-dark cycle with access to food and water ad libitum. All
experiments were carried out in compliance with the USPHS
Guide for Care and Use of Laboratory Animals and approved by
IACUC of University of Alabama at Birmingham with Animal
Protocol Number 091008198.
Preparation of Dyt1 cKO mice and a Dyt1 DGAG
homozygous KI mouse
Two pairs of adult Dyt1 cKO and CT mice were prepared and
genotyped as described earlier [16]. A neonatal Dyt1 DGAG
homozygous KI mouse was prepared by crossing Dyt1 DGAG
heterozygous KI mice and genotyped as described earlier [12,38].
These mice were used for transmission electron microscopy
analysis.
Figure 6. Abnormal nuclear envelope structure of the cerebral cortical neurons in a newborn Dyt1 DGAG homozygous KI mouse. (A)
A representative electron microscope image of the cerebral cortical neurons of a newborn Dyt1 DGAG homozygous KI mouse. This section has two
abnormal nuclear envelope structures (arrows) on the left and right parts of the image. Enlarged images of the left (B) and the right (C) parts of the
nuclear envelope clearly show abnormal nuclear envelope structures in the cerebral cortical neuron. Nucleus (N) and abnormal nuclear envelope
structure (arrow) are shown in each figure. Magnification in A: 6,0006.
doi:10.1371/journal.pone.0024539.g006
Striatum-Specific Dyt1 Conditional KO Mice
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disorders
Behavioral semi-quantitative assessments of motor disorders
were performed as described earlier [12,39]. Mouse from 96 to
139-days old was placed on a table and assessments of hindpaw
clasping, hindpaw dystonia, truncal dystonia and balance
adjustments to a postural challenge were performed. The hindpaw
clasping was assessed as hindpaw movements for postural
adjustment and attempt to straighten up while the mouse was
suspended by the mid-tail. The hindpaw dystonia was assessed as
the increased spacing between the limbs, poor limb coordination,
crouching posture and impairment of gait. Truncal dystonia was
assessed as the flexed posture. Postural challenge was performed
by flipping the mouse onto its back and the ease of righting was
noted.
Accelerated rotarod test
The motor performance was assessed with Economex acceler-
ating rotarod (Columbus Instruments) as described earlier [12].
The apparatus started at an initial speed of 4 rpm. Rod speed was
gradually accelerated at a rate of 0.2 rpm/s. The latency to fall
was measured with a cutoff time of 2 min. Mice from 103 to 146-
days old were tested for three trials on each day for 2 days. The
trials within the same day were performed at approximately
1 hour intervals.
Open-field test
The open-field test was performed under light condition as
described earlier [40,41]. Spontaneous activities of individual mice
from 124 to 167 days old were recorded by infrared light beam
sensors in a 41641631 cm acryl case for 15 min at 1 min
intervals using DigiPro software (AccuScan Instruments).
Beam-walking test
The beam-walking test was performed as described earlier
[12,15,41,42]. Briefly, the beam-walking test was performed
within the last 8 hours of the light period after acclimation to a
sound-attenuated testing room for 1 hour. The mice from 141 to
184 days old were trained to transverse a medium square beam
(14 mm wide) in three consecutive trials each day for 2 days and
tested twice each on the medium square beam and a medium
round beam (17 mm diameter) on the third day. The mice were
then tested twice each on a small round beam (10 mm diameter)
and a small square beam (7 mm wide) on the fourth day. Their
hind paw slips on each side during transverse on the 80 cm-length
beams were counted.
Radioligand binding assay to D2R in the striatal
membrane fractions
Radioligand binding assay to the striatal D2R was performed by
using [
3H] YM-09151-2 based on a method reported earlier [43].
The striata were dissected from three Dyt1 sKO mice and three
CT mice of 268–321 days old (average 284 days old) and
homogenized in nine volumes of ice-cold 50 mM TrisNCl, 8 mM
MgCl2, 5 mM EDTAN2Na, pH 7.1. Each homogenate was
centrifuged at 18,0006 g for 20 min at 4uC and the pellet was
suspended in the same buffer and stored at 280uC. The protein
concentration of the membrane preparation was determined by
Bradford assay using bovine serum albumin as a standard. An
aliquot of the homogenate was suspended in 200 ml of binding
buffer [50 mM TrisNCl, 120 mM NaCl, 5 mM KCl, 5 mM
MgCl2, 1.5 mM CaCl2, 1 mM EDTAN2Na, 10 mM pargyline
hydrochloride (Sigma-Aldrich) and 0.1% ascorbic acid, pH 7.4]
with 0.03–0.96 nM [
3H] YM-09151-2 (2.64TBq/mmol, Perkin
Elmer). The reaction mixture was incubated at 25uC for 40 min,
and then rapidly filtered under vacuum through glass microfibre
GF/B filter (Whatman). The filter was then washed four times
with 4 ml of the ice-cold binding buffer without the isotope and
then dried. The radioactivity of the filters was measured in 6 ml of
ScintiSafe Econo1 (Fisher Scientific) by a Beckman liquid
scintillation counter. Non-specific binding of [
3H] YM-09151-2
was measured in presence of 30 mM (S)-(-)-sulpiride (Sigma-
Aldrich). The experiments were performed in duplicate.
HPLC analysis
Striata were dissected from the brains of 13 Dyt1 sKO and 13
CT mice from 302 to 345 days old and homogenized in ice-cold
0.2 N perchloric acid. The homogenate were centrifuged for
15 min at 15,0006ga t4 uC to remove debris. Twenty microliters
of the supernatant representing 2 mg of tissue, was the applied to a
C18C reverse phase HPLC column (Varian) connected to an ESA
model 5200A electrochemical detector. DA, DOPAC and HVA
were analyzed using a running buffer of 50 mM potassium
phosphate buffer with 0.5 mM octyl sulfate (Sigma) and 8%
acetonitrile as described earlier [12,15,41]. DA, DOPAC, and
HVA were separated at 0.8 ml/min and quantified by comparing
to the standard reagents (Sigma).
Transmission electron microscopy analysis
Brain sections for transmission electron microscopy were
prepared as described earlier [14]. Dyt1 sKO and their CT mice
(n=1 each, 6 weeks of age), Dyt1 cKO mice and their CT mice
(n=2 each, 8 weeks of age), and a newborn Dyt1 DGAG
homozygous KI mouse were perfused with chilled 0.1 M
phosphate-buffered saline (pH 7.4) followed by Karnovsky’s
fixative in phosphate buffered 2% glutaraldehyde and 2.5%
paraformaldehyde. The brains were dissected out and left in
Karnovsky’s fixative overnight. The tissue was then trimmed and
washed in cacodylate buffer with no further additives. Microwave
fixation was used with the secondary 2% osmium tetroxide
fixative, followed by the addition of 3% potassium ferricyanide for
30 minutes. After washing with water, saturated uranyl acetate was
added for en bloc staining. The tissue was dehydrated in a series of
increasing concentrations of ethanol starting at 50%. Acetonitrile
was used as the transition fluid between ethanol and the epoxy.
Infiltration series was done with an epoxy mixture using the epon
substitute Lx112. The resulting blocks were polymerized at 90uC
overnight, trimmed with a razor blade, and ultrathin sectioned
with diamond knives. Sections were then stained with uranyl
acetate and lead citrate, and the nuclear envelopes in the striata of
Dyt1 sKO and their CT mice, and cerebral cortices of Dyt1 cKO
mice, their CT mice and a Dyt1 DGAG homozygous KI mouse
were examined or photographed with a Hitachi H600 transmis-
sion electron microscope.
Statistics
Data in the open-field test, latency to fall in the accelerated
rotarod, and HPLC were analyzed by ANOVA mixed model with
SAS/STAT Analyst program (Version 9.1.3; SAS institute Inc.
NC) as described earlier [12,16,41]. The turnovers of metabolites
were analyzed as the ratio of the neurochemicals after natural log
transformation to obtain a normal distribution. Slips numbers of
hindpaws in beam-walking test were analyzed by logistic
regression (GENMOD) with Poisson distribution using GEE
model in the software. Sex, age and body weight were input as
variables. Vertical movement numbers in the open-field test,
latency to fall in the accelerated rotarod test, and slips numbers in
Striatum-Specific Dyt1 Conditional KO Mice
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mation to obtain a normal distribution. The data in CT mice were
normalized to zero. Radioligand binding data were analyzed by
Student’s t test. Bmax and Kd of each mouse were individually
calculated in Scatchard plot and those of each genotype were
compared. Significance was assigned at p,0.05.
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